{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:58:19Z","timestamp":1771955899390,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T00:00:00Z","timestamp":1219363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s11154-008-9095-z","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T06:49:02Z","timestamp":1219301342000},"page":"27-32","source":"Crossref","is-referenced-by-count":12,"title":["Non-traditional metabolic pathways of adrenal steroids"],"prefix":"10.1007","volume":"10","author":[{"given":"Richard J.","family":"Auchus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,22]]},"reference":[{"key":"9095_CR1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0039-128X(99)00054-9","volume":"64","author":"N Bruchovsky","year":"1999","unstructured":"Bruchovsky N, Wilson JD. Discovery of the role of dihydrotestosterone in androgen action. Steroids. 1999;64:753\u20139. doi: 10.1016\/S0039-128X(99)00054-9 .","journal-title":"Steroids."},{"key":"9095_CR2","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1016\/S0021-9258(18)94513-8","volume":"243","author":"N Bruchovsky","year":"1968","unstructured":"Bruchovsky N, Wilson JD. The intranuclear binding of testosterone and 5\u03b1-androstan-17\u03b2-ol-3-one by rat prostate. J Biol Chem. 1968;243:5953\u201360.","journal-title":"J Biol Chem."},{"key":"9095_CR3","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1016\/S0021-9258(17)33036-3","volume":"251","author":"RJ Moore","year":"1976","unstructured":"Moore RJ, Wilson JD. Steroid 5\u03b1-reductase in cultured human fibroblasts. Biochemical and genetic evidence for two distinct enzyme activities. J Biol Chem. 1976;251:5895\u2013900.","journal-title":"J Biol Chem."},{"key":"9095_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/354159a0","volume":"354","author":"S Andersson","year":"1991","unstructured":"Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of a steroid 5\u03b1-reductase 2 gene in male pseudohermaphroditism. Nature. 1991;354:159\u201361. doi: 10.1038\/354159a0 .","journal-title":"Nature."},{"key":"9095_CR5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1095\/biolreprod29.5.1194","volume":"29","author":"DJ Chase","year":"1983","unstructured":"Chase DJ, Payne AH. Changes in Leydig cell function during sexual maturation in the mouse. Biol Reprod. 1983;29:1194\u2013200. doi: 10.1095\/biolreprod29.5.1194 .","journal-title":"Biol Reprod."},{"key":"9095_CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/joe.0.1190257","volume":"119","author":"JW Sheffield","year":"1988","unstructured":"Sheffield JW, O\u2019Shaughnessy PJ. Testicular steroid metabolism during development in the normal and hypogonadal mouse. J Endocrinol. 1988;119:257\u201364.","journal-title":"J Endocrinol."},{"key":"9095_CR7","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1210\/endo.139.9.6183","volume":"139","author":"RS Ge","year":"1998","unstructured":"Ge RS, Hardy MP. Variation in the end products of androgen biosynthesis and metabolism during postnatal differentiation of rat Leydig cells. Endocrinology. 1998;139:3787\u201395. doi: 10.1210\/en.139.9.3787 .","journal-title":"Endocrinology."},{"key":"9095_CR8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1095\/biolreprod60.4.855","volume":"60","author":"RS Ge","year":"1999","unstructured":"Ge RS, Hardy DO, Catterall JF, Hardy MP. Opposing changes in 3\u03b1-hydroxysteroid dehydrogenase oxidative and reductive activities in rat leydig cells during pubertal development. Biol Reprod. 1999;60:855\u201360. doi: 10.1095\/biolreprod60.4.855 .","journal-title":"Biol Reprod."},{"key":"9095_CR9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2605.1999.00175.x","volume":"22","author":"MB Frungieri","year":"1999","unstructured":"Frungieri MB, Gonzalez-Calvar SI, Bartke A, Calandra RS. Influence of age and photoperiod on steroidogenic function of the testis in the golden hamster. Int J Androl. 1999;22:243\u201352. doi: 10.1046\/j.1365-2605.1999.00175.x .","journal-title":"Int J Androl."},{"key":"9095_CR10","doi-asserted-by":"crossref","first-page":"E975","DOI":"10.1152\/ajpcell.1994.266.4.C975","volume":"266","author":"GP Risbriger","year":"1994","unstructured":"Risbriger GP, Davies A. Isolation of rat Leydig cells and precursor forms after administration of ethane dimethane sulfonate. Am J Physiol. 1994;266:E975\u2013979.","journal-title":"Am J Physiol."},{"key":"9095_CR11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0039-128X(80)90027-6","volume":"36","author":"R Carmichael","year":"1980","unstructured":"Carmichael R, Belanger A, Cusan L, Seguin C, Caron S, Labrie F. Increased testicular 5\u03b1-androstane-3\u03b1,17\u03b2-diol formation induced by treatment with [D-Ser (TBU) 6, des-Gly-NH2(10)] LHRH ethylamide in the rat. Steroids. 1980;36:383\u201391. doi: 10.1016\/0039-128X(80)90027-6 .","journal-title":"Steroids."},{"key":"9095_CR12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/endo-100-4-1027","volume":"100","author":"WH Moger","year":"1977","unstructured":"Moger WH. Serum 5\u03b1-androstane-3\u03b1,17\u03b2-diol, androsterone, and testosterone concentrations in the male rat. Influence of age and gonadotropin stimulation. Endocrinology 1977;100:1027\u201332.","journal-title":"Endocrinology"},{"key":"9095_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2004.04.009","volume":"222","author":"MS Mahendroo","year":"2004","unstructured":"Mahendroo MS, Wilson JD, Richardson JA, Auchus RJ. Steroid 5\u03b1-reductase 1 promotes 5\u03b1-androstane-3\u03b1,17\u03b2-diol synthesis in immature mouse testes by two pathways. Mol Cell Endocrinol. 2004;222:113\u201320. doi: 10.1016\/j.mce.2004.04.009 .","journal-title":"Mol Cell Endocrinol."},{"key":"9095_CR14","doi-asserted-by":"crossref","first-page":"12256","DOI":"10.1073\/pnas.220412297","volume":"97","author":"G Shaw","year":"2000","unstructured":"Shaw G, Renfree MB, Leihy MW, Shackleton CH, Roitman E, Wilson JD. Prostate formation in a marsupial is mediated by the testicular androgen 5\u03b1-androstane-3\u03b1,17\u03b2-diol. Proc Natl Acad Sci U S A. 2000;97:12256\u20139. doi: 10.1073\/pnas.220412297 .","journal-title":"Proc Natl Acad Sci U S A."},{"key":"9095_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-4165(87)90063-8","volume":"924","author":"B Eckstein","year":"1987","unstructured":"Eckstein B, Borut A, Cohen S. Metabolic pathways for androstanediol formation in immature rat testis microsomes. Biochim Biophys Acta. 1987;924:1\u20136.","journal-title":"Biochim Biophys Acta."},{"key":"9095_CR16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/en.2002-220721","volume":"144","author":"JD Wilson","year":"2003","unstructured":"Wilson JD, Auchus RJ, Leihy MW, Guryev OL, Estabrook RW, Osborn SM, et al. 5\u03b1-androstane-3\u03b1,17\u03b2-diol is formed in tammar wallaby pouch young testes by a pathway involving 5\u03b1-pregnane-3\u03b1,17\u03b1-diol-20-one as a key intermediate. Endocrinology. 2003;144:575\u201380. doi: 10.1210\/en.2002-220721 .","journal-title":"Endocrinology."},{"key":"9095_CR17","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/S0021-9258(18)62328-2","volume":"246","author":"DW Frederiksen","year":"1971","unstructured":"Frederiksen DW, Wilson JD. Partial characterization of the nuclear reduced nicotinamide adenine dinucleotide phosphate: \u0394 4\u20133-ketosteroid 5 \u03b1-oxidoreductase of rat prostate. J Biol Chem 1971;246:2584\u201393.","journal-title":"J Biol Chem"},{"key":"9095_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3510067","volume":"351","author":"TM Penning","year":"2000","unstructured":"Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, et al. Human 3\u03b1-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J. 2000;351:67\u201377. doi: 10.1042\/0264-6021:3510067 .","journal-title":"Biochem J."},{"key":"9095_CR19","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","volume":"273","author":"RJ Auchus","year":"1998","unstructured":"Auchus RJ, Lee TC, Miller WL. Cytochrome b 5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J Biol Chem. 1998;273:3158\u201365. doi: 10.1074\/jbc.273.6.3158 .","journal-title":"J Biol Chem."},{"key":"9095_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.abb.2003.07.003","volume":"418","author":"MK Gupta","year":"2003","unstructured":"Gupta MK, Guryev OL, Auchus RJ. 5\u03b1-reduced C21 steroids are substrates for human cytochrome P450c17. Arch Biochem Biophys. 2003;418:151\u201360. doi: 10.1016\/j.abb.2003.07.003 .","journal-title":"Arch Biochem Biophys."},{"key":"9095_CR21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1530\/acta.0.1110116","volume":"111","author":"T Backstrom","year":"1986","unstructured":"Backstrom T, Andersson A, Baird DT, Selstam G. The human corpus luteum secretes 5\u03b1-pregnane-3,20-dione. Acta Endocrinol (Copenh). 1986;111:116\u201321.","journal-title":"Acta Endocrinol (Copenh)."},{"key":"9095_CR22","first-page":"3136","volume":"80","author":"L Milewich","year":"1995","unstructured":"Milewich L, Mendonca BB, Arnhold I, Wallace AM, Donaldson MD, Wilson JD, et al. Women with steroid 5\u03b1-reductase 2 deficiency have normal concentrations of plasma 5\u03b1-dihydroprogesterone during the luteal phase. J Clin Endocrinol Metab. 1995;80:3136\u20139. doi: 10.1210\/jc.80.11.3136 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9095_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s004180050210","volume":"109","author":"H Yokoi","year":"1998","unstructured":"Yokoi H, Tsuruo Y, Miyamoto T, Ishimura K. Steroid 5\u03b1-reductase type 1 immunolocalized in the adrenal gland of normal, gonadectomized, and sex hormone-supplemented rats. Histochem Cell Biol. 1998;109:127\u201334. doi: 10.1007\/s004180050210 .","journal-title":"Histochem Cell Biol."},{"key":"9095_CR24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tem.2006.10.001","volume":"17","author":"NA Hanley","year":"2006","unstructured":"Hanley NA, Arlt W. The human fetal adrenal cortex and the window of sexual differentiation. Trends Endocrinol Metab. 2006;17:391\u20137. doi: 10.1016\/j.tem.2006.10.001 .","journal-title":"Trends Endocrinol Metab."},{"key":"9095_CR25","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM198511073131903","volume":"313","author":"RE Peterson","year":"1985","unstructured":"Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med. 1985;313:1182\u201391.","journal-title":"N Engl J Med."},{"key":"9095_CR26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","volume":"36","author":"CE Fl\u00fcck","year":"2004","unstructured":"Fl\u00fcck CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet. 2004;36:228\u201330. doi: 10.1038\/ng1300 .","journal-title":"Nat Genet."},{"key":"9095_CR27","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","volume":"363","author":"W Arlt","year":"2004","unstructured":"Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet. 2004;363:2128\u201335. doi: 10.1016\/S0140-6736(04)16503-3 .","journal-title":"Lancet."},{"key":"9095_CR28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","volume":"76","author":"N Huang","year":"2005","unstructured":"Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, et al. Diversity and function of mutations in P450 oxidoreductase in patients with Antley\u2013Bixler syndrome and disordered steroidogenesis. Am J Hum Genet. 2005;76:729\u201349. doi: 10.1086\/429417 .","journal-title":"Am J Hum Genet."},{"key":"9095_CR29","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1016\/S0021-9258(19)83930-3","volume":"261","author":"K Yanagibashi","year":"1986","unstructured":"Yanagibashi K, Hall PF. Role of electron transport in the regulation of the lyase activity of C-21 side-chain cleavage P450 from porcine adrenal and testicular microsomes. J Biol Chem 1986;261:8429\u201333.","journal-title":"J Biol Chem"},{"key":"9095_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1097-201","volume":"17","author":"DH Geller","year":"1997","unstructured":"Geller DH, Auchus RJ, Mendon\u00e7a BB, Miller WL. The genetic and functional basis of isolated 17,20 lyase deficiency. Nat Genet. 1997;17:201\u20135. doi: 10.1038\/ng1097-201 .","journal-title":"Nat Genet."},{"key":"9095_CR31","first-page":"1169","volume":"13","author":"RJ Auchus","year":"1999","unstructured":"Auchus RJ, Miller WL. Molecular modeling of human P450c17 (17\u03b1-hydroxylase\/17,20-lyase): Insights into reaction mechanisms and effects of mutations. Mol Endocrinol. 1999;13:1169\u201382. doi: 10.1210\/me.13.7.1169 .","journal-title":"Mol Endocrinol."},{"key":"9095_CR32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0039-128X(03)00115-6","volume":"68","author":"C Shackleton","year":"2003","unstructured":"Shackleton C, Malunowicz E. Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome. Steroids. 2003;68:707\u201317. doi: 10.1016\/S0039-128X(03)00115-6 .","journal-title":"Steroids."},{"key":"9095_CR33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ajmg.a.30171","volume":"129","author":"C Shackleton","year":"2004","unstructured":"Shackleton C, Marcos J, Arlt W, Hauffa BP. Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): A disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. Am J Med Genet A. 2004;129:105\u201312. doi: 10.1002\/ajmg.a.30171 .","journal-title":"Am J Med Genet A."},{"key":"9095_CR34","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2005-2460","volume":"91","author":"K Homma","year":"2006","unstructured":"Homma K, Hasegawa T, Nagai T, Adachi M, Horikawa R, Fujiwara I, et al. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab. 2006;91:2643\u20139. doi: 10.1210\/jc.2005-2460 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9095_CR35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","volume":"327","author":"DA Ehrmann","year":"1992","unstructured":"Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992;327:157\u201362.","journal-title":"N Engl J Med."},{"key":"9095_CR36","first-page":"1686","volume":"79","author":"RL Rosenfield","year":"1994","unstructured":"Rosenfield RL, Barnes RB, Ehrmann DA. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994;79:1686\u201392. doi: 10.1210\/jc.79.6.1686 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9095_CR37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","volume":"335","author":"JE Nestler","year":"1996","unstructured":"Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17\u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996;335:617\u201323. doi: 10.1056\/NEJM199608293350902 .","journal-title":"N Engl J Med."},{"key":"9095_CR38","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","volume":"88","author":"M Fassnacht","year":"2003","unstructured":"Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W. Beyond adrenal and ovarian androgen generation: Increased peripheral 5\u03b1-reductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:2760\u20136. doi: 10.1210\/jc.2002-021875 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9095_CR39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","volume":"62","author":"A Kumar","year":"2005","unstructured":"Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2005;62:644\u20139. doi: 10.1111\/j.1365-2265.2005.02256.x .","journal-title":"Clin Endocrinol (Oxf)."},{"key":"9095_CR40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2265.1990.tb00868.x","volume":"32","author":"DL Thompson","year":"1990","unstructured":"Thompson DL, Horton N, Rittmaster RS. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women. Clin Endocrinol (Oxf). 1990;32:283\u201392. doi: 10.1111\/j.1365-2265.1990.tb00868.x .","journal-title":"Clin Endocrinol (Oxf)."},{"key":"9095_CR41","first-page":"245","volume":"21","author":"PC White","year":"2000","unstructured":"White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245\u201391. doi: 10.1210\/er.21.3.245 .","journal-title":"Endocr Rev."},{"key":"9095_CR42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0960-0760(92)90030-M","volume":"42","author":"CB Whorwood","year":"1992","unstructured":"Whorwood CB, Ueshiba H, del Blazo P. Plasma levels of C19 steroid glucuronides in pre-menopausal women with non-classical congenital adrenal hyperplasia. J Steroid Biochem Mol Biol. 1992;42:211\u201321. doi: 10.1016\/0960-0760(92)90030-M .","journal-title":"J Steroid Biochem Mol Biol."},{"key":"9095_CR43","first-page":"1","volume":"52","author":"EE Baulieu","year":"1997","unstructured":"Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res. 1997;52:1\u201332.","journal-title":"Recent Prog Horm Res."},{"key":"9095_CR44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0960-0760(95)00233-2","volume":"56","author":"R Rupprecht","year":"1996","unstructured":"Rupprecht R, Hauser CA, Trapp T, Holsboer F. Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J Steroid Biochem Mol Biol. 1996;56:163\u20138. doi: 10.1016\/0960-0760(95)00233-2 .","journal-title":"J Steroid Biochem Mol Biol."},{"key":"9095_CR45","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","volume":"96","author":"LD Griffin","year":"1999","unstructured":"Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A. 1999;96:13512\u20137. doi: 10.1073\/pnas.96.23.13512 .","journal-title":"Proc Natl Acad Sci U S A."},{"key":"9095_CR46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/09513590601024681","volume":"22","author":"AR Genazzani","year":"2006","unstructured":"Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, et al. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol. 2006;22:627\u201335. doi: 10.1080\/09513590601024681 .","journal-title":"Gynecol Endocrinol."}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-008-9095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-008-9095-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-008-9095-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T07:43:42Z","timestamp":1631691822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-008-9095-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,22]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["9095"],"URL":"https:\/\/doi.org\/10.1007\/s11154-008-9095-z","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,22]]}}}